Login
Toggle navigation
Videos
Categories
Trending
MD/CEO Jordan Kevol discusses latest company announcements in an interview with The Market Herald in Perth, Western Australia.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Tommy Logtenberg is the CEO of The Market Herald.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Michael Knaap Chief Executive Officer and Managing Director, Monash IVF Group Ltd
00:10:00
Emperor Energy welcomes MoU with Cooper Energy | Jane Norman, CEO, Cooper Energy LtdCOE:ASX
00:10:00
Transformative Trends in Commercial Real Estate: A Strategic Perspective | Orlando Bravo, Founder, Thoma Bravo.
00:10:00
Intrepid Metals Corp CEO Ken Brophy discusses the company's move to OTCQB, progress on the Corral Copper project, and ambitious plans for exploration and expansion in Arizona's mining-rich regions.|Ken Brophy CEO of Intrepid Metals Corp.
00:10:00
To consistently grow capital through investment|Clive R Holmes,Managing Partner,Silverfern CoInvestment Partners
00:10:00
Assessing Energy Challenges and Climate Solutions | John Doerr, Chairman, Kleiner Perkins.
00:10:00
Aurumin Limited: Company Overview and Gold Projects Presentation
00:10:00
Bangkok Post's Women of the Year in Energy Category Recognized for Leadership |Somruedee Chaimongkol, CEO, Banpu Public Company.
00:10:00
Revenues for Albert Technologies increased by over three times in 2018 | Antoine Vatar, CEO, Albert Technologies Ltd ALB:LSE
00:10:00
CHSC: Uncovered Asia's Steel Giant | Kuei-Sung Tseng - Chairman of Chung Hung Steel Corp
00:10:00
Exclusive Interview: Insights on Mexico City's New Airport Construction | Ricardo Dueñas Espriu - CEO of Grupo Aeroportuario Centro Norte
00:10:00
Navigating the landscape of medical cannabis opportunities and risks with insights from industry experts |Josh Fegan, CEO,Althea Group.